| Entry |
|
|---|
| Name |
L-Carnitine;
L-gamma-Trimethyl-beta-hydroxybutyrobetaine;
Vitamin BT;
3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt;
Levocarnitine;
(R)-Carnitine
|
|---|
| Formula |
C7H15NO3
|
|---|
| Exact mass |
161.1052
|
|---|
| Mol weight |
161.1989
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Reaction |
|
|---|
| Pathway |
|
|---|
| Enzyme |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16AA Amino acids and derivatives
A16AA01 Levocarnitine
D02176 Levocarnitine (JAN/USP/INN) <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
399 Miscellaneous
3999 Others
D02176 Levocarnitine (JAN/USP/INN)
Risk category of Japanese OTC drugs [BR:br08312]
Third-class OTC drugs
Inorganic and organic chemicals
Carnitine
D02176 Levocarnitine (JAN/USP/INN)
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D02176
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D02176
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 11
1 C1b C 23.3100 -15.1200
2 N1d N 24.4709 -15.8958 #+
3 C1c C 22.0674 -15.7441
4 C1a C 24.5235 -17.2900
5 C1a C 25.8010 -16.3333
6 C1b C 20.8366 -15.1141
7 O1a O 22.0674 -17.2609
8 C6a C 19.6757 -15.8725
9 O6a O 18.3981 -15.2482 #-
10 O6a O 19.6698 -17.1792
11 C1a C 25.8233 -15.1958
BOND 10
1 1 2 1
2 1 3 1
3 2 4 1
4 2 5 1
5 3 6 1
6 3 7 1 #Down
7 6 8 1
8 8 9 1
9 8 10 2
10 2 11 1
|
|---|
